Cas:48145-04-6 2-PHENOXYETHYL ACRYLATE manufacturer & supplier

We serve Chemical Name:2-PHENOXYETHYL ACRYLATE CAS:48145-04-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-PHENOXYETHYL ACRYLATE

Chemical Name:2-PHENOXYETHYL ACRYLATE
CAS.NO:48145-04-6
Synonyms:EINECS 256-360-6;MFCD00053696;Acrylic Acid 2-Phenoxyethyl Ester;Ethylene glycol phenyl ether acrylate;Ethylene Glycol Monophenyl Ether Acrylate;2-PHENOXYETHYL ACRYLATE
Molecular Formula:C11H12O3
Molecular Weight:192.21100
HS Code:2916129000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:84 °C0.2 mm Hg(lit.)
Density:1.104 g/mL at 25 °C(lit.)
Index of Refraction:n20/D 1.518(lit.)
PSA:35.53000
Exact Mass:192.07900
LogP:1.79460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3082 9 / PGIII
Packing Group:


Contact us for information like EINECS 256-360-6 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-PHENOXYETHYL ACRYLATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethylene glycol phenyl ether acrylate Use and application,2-PHENOXYETHYL ACRYLATE technical grade,usp/ep/jp grade.


Related News: For example, by using molecular modeling tools to achieve rapid de novo design of new enzymes, it may be possible to increase activity, enhance temperature stability, or improve solvent compatibility to better align with the process in question. 2-((R)-2-((R)-benzylsulfinyl)-4-oxoazetidin-1-yl)-N-(6-cyclohexylhexyl)acetamide manufacturers Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 1-(5-methylisoxazol-3-yl-carbonyl)-3-(2-phenylbenzo[d][1,3]dioxol-6-yl)thiourea suppliers The pivotal TULIP (Treatment of Uncontrolled Lupus via the Interferon Pathway) phase III programme includes two trials, TULIP-1 and TULIP-2, that evaluated the efficacy and safety of anifrolumab versus placebo. N-(3-(3,4-diethylphenyl)-1-oxo-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)-4-(2-oxo-1,2,4,5-tetrahydro-3H-benzo[d][1,3]diazepin-3-yl)piperidine-1-carboxamide vendor & factory.